You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hlx01

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Non Hodgkin's Lymphoma Trial (HLX01, Rituximab)

Completed
  • B-cell Non Hodgkin's Lymphoma
  • (no location specified)
May 4, 2022

Rheumatoid Arthritis Trial (HLX01)

Completed
  • Rheumatoid Arthritis
  • HLX01
  • (no location specified)
May 4, 2022

Moderately to Severely Active Rheumatoid Arthritis Trial in Jiujiang (HLX01, Methotrexate(MTX))

Completed
  • Moderately to Severely Active Rheumatoid Arthritis
  • Jiujiang, Jiangxi, China
    Jiujiang No.1 peoples's hospital
May 4, 2022

B-cell Non Hodgkin's Lymphoma Trial in Beijing (HLX01, Rituximab, CHOP)

Completed
  • B-cell Non Hodgkin's Lymphoma
  • HLX01
  • +2 more
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
May 4, 2022

CD20-positive Follicular Lymphoma, With Low Tumour Burden Trial (HLX01, Mabthera®)

Withdrawn
  • CD20-positive Follicular Lymphoma, With Low Tumour Burden
  • (no location specified)
Dec 10, 2020